Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Man, Ellen Ps"'
Autor:
Tsoi, Ho1 (AUTHOR), Man, Ellen PS1 (AUTHOR), Leung, Man‐Hong1 (AUTHOR), Mok, Ka‐Chun1 (AUTHOR), Chau, Ka‐Man1 (AUTHOR), Wong, Lai‐San2 (AUTHOR), Chan, Wing‐Lok3 (AUTHOR), Chan, Sum‐Yin2 (AUTHOR), Luk, Mai‐Yee2 (AUTHOR), Cheng, Cheuk‐Nam1 (AUTHOR), Khoo, Ui‐Soon1 (AUTHOR) uskhoo@pathology.hku.hk
Publikováno v:
Clinical & Translational Medicine. Oct2021, Vol. 11 Issue 10, p1-6. 6p.
Autor:
Tsoi, Ho, Lok, Johann, Man, Ellen PS, Cheng, Cheuk‐Nam, Leung, Man‐Hong, You, Chan‐Ping, Chan, Sum‐Yin, Chan, Wing‐Lok, Khoo, Ui‐Soon
Publikováno v:
Journal of Pathology; Oct2023, Vol. 261 Issue 2, p156-168, 13p
Autor:
Mok, Ka-Chun, Tsoi, Ho, Man, Ellen Ps, Leung, Man-Hong, Chau, Ka Man, Wong, Lai-San, Chan, Wing-Lok, Chan, Sum-Yin, Luk, Mai-Yee, Chan, Jessie YW, Leung, Jackie KM, Chan, Yolanda HY, Batalha, Sellma, Lau, Virginia, Siu, David CW, Lee, Terence KW, Gong, Chun, Khoo, Ui-Soon
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are members of the voltage-gated cation channel family known to be expressed in the heart and central nervous system. Ivabradine, a small molecule HCN channel-blocker, is FDA-approved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eed6644fc327a56a3c19d7d87b10118
https://www.repository.cam.ac.uk/handle/1810/330280
https://www.repository.cam.ac.uk/handle/1810/330280
Autor:
Mok, Ka‐Chun, Tsoi, Ho, Man, Ellen PS, Leung, Man‐Hong, Chau, Ka Man, Wong, Lai‐San, Chan, Wing‐Lok, Chan, Sum‐Yin, Luk, Mai‐Yee, Chan, Jessie Y.W., Leung, Jackie K.M., Chan, Yolanda H.Y., Batalha, Sellma, Lau, Virginia, Siu, David C.W., Lee, Terence K.W., Gong, Chun, Khoo, Ui‐Soon
Publikováno v:
Clinical & Translational Medicine; Nov2021, Vol. 11 Issue 11, p1-22, 22p
Autor:
Gong, Chun, Man, Ellen PS, Tsoi, Ho, Lee, Terence KW, Lee, Paul, Ma, Sai-Ting, Wong, Lai-San, Luk, Mai-Yee, Rakha, Emad A, Green, Andrew R, Ellis, Ian O, Lam, Eric W-F, Cheung, Kwok-Leung, Khoo, Ui-Soon
Purpose: Adjuvant tamoxifen treatment revolutionized the management of estrogen receptor (ER)-positive breast cancers to prevent cancer recurrence; however, drug resistance compromises its clinical efficacy. The mechanisms underlying tamoxifen resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6b0a639148f8db44a03e49abee19942
https://www.repository.cam.ac.uk/handle/1810/287694
https://www.repository.cam.ac.uk/handle/1810/287694
Autor:
Leung, Man-Hong, Tsoi, Ho, Gong, Chun, Man, Ellen PS, Zona, Stefania, Yao, Shang, Lam, Eric W.-F., Khoo, Ui-Soon
Publikováno v:
Cancers; Mar2020, Vol. 12 Issue 3, p533, 1p